The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
Welcome to the all-new HOPA Resource Library where we consider all searches “advanced searches.”
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.Join or renew your membership today!
We are pleased to share that research presented at the 2014 HOPA Annual Conference by members Jennifer L Niccolai, PharmD and Danielle L Roman, PharmD, has been published in a recent Journal of Oncology Practice.Read it all here!
Early bird registration rates end today for the HOPA Annual Conference! Register
Voting members of HOPA: Please vote on the proposed amendments to the HOPA Bylaws.
Be sure to purchase your HOPA apparel in time for the Annual Conference.
Make the most of your conference experience with in depth preconference sessions.
Nivolumab (OPDIVO) approved for treatment of patients with locally advanced or metastatic urothelial carcinoma...
Rucaparib (RUBRACA) approved for treatment of patients with deleterious BRCA mutation associated advanced ovarian cancer...
Daratumumab (DARZALEX) approved for treatment of patients with multiple myeloma who have received at least on prior therapy...
Nivolumab (OPDIVO) approved for the treatment of recurrent or metastatic squamous cell carcinoma of the head and the neck...
Registration is now open: March 29–April 1, 2017
BCOP Programming: Specialty Sessions & Updates Course
HOPA Oncology Pharmacy Practice Management Program
Now pharmacists can fulfill all of their BCOP recertification education with HOPA— the experts in clinical oncology pharmacy. HOPA recently was awarded status as a BCOP recertification credit provider by the Board of Pharmacy Specialties (BPS), and will now provide 38 credits of education per year in a variety of delivery options.
The HOPA BCOP recertification courses address the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.Learn More
HOPA has created several patient education videos for you to share with your patients and their families.